表紙
市場調査レポート

HIV-1 感染症:世界の治験レビュー

HIV-1 Infection Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 232265
出版日 ページ情報 英文 164 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
HIV-1 感染症:世界の治験レビュー HIV-1 Infection Global Clinical Trials Review, H2, 2014
出版日: 2014年11月30日 ページ情報: 英文 164 Pages
概要

HIV 感染症はヒト免疫不全ウィルスによるウィルス感染症です。この感染症は長期間に渡って免疫システムを破壊し、体が感染症と戦うことでより強くなっていきます。HIV 感染症には2種類あり、HIV-1型はより感染性が高くて伝染力が強く、伝播力も早くて、世界的に広がったHIV感染症の原因のほとんどがこのタイプです。それに対して、HIV-2型の伝播は遅く、主に西アフリカに限られています。HIV-1型感染症は、血液、性的接触、母子間を通じて拡大します。感染すると、最大で10年間は何の兆候も出ずに発症しませんが、その間も感染を拡大させることは可能です。HIV-1型の症状には熱、頭痛、のどの痛み、下痢、口のびらん、様々なタイプの発疹、リンパ腺の腫れ、疲労、膣内イースト菌感染症、筋肉痛などがあります。治療は抗ウィルス治療薬を組み合わせます。HIV-1感染症患者は、ウイルスが薬に対して耐性を示すようになるのを避けるために、すべての薬物を服用をしなければなりません。合併症にはHIV関連の認知症、癌、HIV関連リポジストロフィー、慢性的な体重の減少、カンジダ症のような日和見感染症などがあります。

当レポートでは、HIV-1 感染症に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、G7諸国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、お届けします。

イントロダクション

  • HIV-1 感染症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 上位5ヶ国における治験件数; アジア太平洋地域
    • 上位5ヶ国における治験件数; 欧州
    • 主要国における治験件数; 北米
    • 上位5ヶ国における治験件数; 中東/アフリカ地域
    • 上位5ヶ国における治験件数; 中南米

G7諸国における治験件数: HIV-1 感染症治験件数の感染症治験件数に対する比率

フェーズ(相)別治験件数: G7諸国

G7諸国における治験件数:フェーズ(相)別

E7諸国における治験件数: HIV-1 感染症治験件数の感染症治験件数に対する比率

フェーズ(相)別治験件数: E7諸国

E7諸国における治験件数:フェーズ(相)別

フェーズ(相)別治験件数

  • フェーズ(相)別の進行中治験件数

進捗状況別の治験件数

評価項目別の治験件数

未完了の治験

一定期間に採用された被験者数

スポンサーの種類別の治験件数

有望なスポンサー

治験主要参加企業 - HIV-1 感染症治療薬

有望な薬剤

最新治験ニュース: HIV-1 感染症

治験のプロファイル

  • 代表的な企業の治験の概要
    • GlaxoSmithKline plc
    • Gilead Sciences, Inc.
    • Merck & Co., Inc.
    • C. H. Boehringer Sohn AG & Co. KG
    • Pfizer Inc.
    • F. Hoffmann-La Roche Ltd.
    • Johnson & Johnson
    • Bristol-Myers Squibb Company
    • Abbott Laboratories
    • Janssen R&D Ireland
  • 代表的な研究機関/病院の治験の概要
    • The National Institute of Allergy and Infectious Diseases
    • French National Agency for Research on AIDS and Viral Hepatitis
    • AIDS Clinical Trials Group
    • University of California, San Francisco
    • Hospital Clinic de Barcelona
    • University of Washington
    • Imperial College London
    • University of North Carolina
    • International Partnership For Microbicides
    • Medical Research Council

5大治験プロファイル 1

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2454CTIDB

GlobalData's clinical trial report, "HIV-1 Infection Global Clinical Trials Review, H2, 2014" provides data on the HIV-1 Infection clinical trial scenario. This report provides elemental information and data relating to the clinical trials on HIV-1 Infection. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating HIV-1 Infection. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • HIV-1 Infection
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of HIV-1 Infection to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of HIV-1 Infection to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of HIV-1 Infection
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in HIV-1 Infection Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on HIV-1 Infection
    • Nov 11, 2014: AbbVie to Present Results from Studies in Chronic Hepatitis C Patients with HIV-1 Co-Infection (TURQUOISE-I) and Liver Transplant Recipients (CORAL-I) at The Liver Meeting 2014
    • Nov 03, 2014: Merck Announces Data from 48-Week Phase 2b Study of Investigational HIV Therapy Doravirine (MK-1439) in Treatment-Naive Patients
    • Oct 13, 2014: CytoDyn Announces 100% Success With PRO 140 in Four-Week Monotherapy Clinical Trial
    • Sep 24, 2014: Gilead's Investigational Tenofovir Alafenamide (TAF)-Based Single Tablet HIV Regimen Meets 48-Week Primary Objective in Two Phase 3 Studies
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Gilead Sciences, Inc.
      • Clinical Trial Overview of Gilead Sciences, Inc.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • Abbott Laboratories
      • Clinical Trial Overview of Abbott Laboratories
      • Janssen R&D Ireland
      • Clinical Trial Overview of Janssen R&D Ireland
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • French National Agency for Research on AIDS and Viral Hepatitis
      • Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis
      • AIDS Clinical Trials Group
      • Clinical Trial Overview of AIDS Clinical Trials Group
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
      • Hospital Clinic de Barcelona
      • Clinical Trial Overview of Hospital Clinic de Barcelona
      • University of Washington
      • Clinical Trial Overview of University of Washington
      • Imperial College London
      • Clinical Trial Overview of Imperial College London
      • University of North Carolina
      • Clinical Trial Overview of University of North Carolina
      • International Partnership For Microbicides
      • Clinical Trial Overview of International Partnership For Microbicides
      • Medical Research Council
      • Clinical Trial Overview of Medical Research Council
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • HIV-1 Infection Therapeutics, Global, Clinical Trials by Region, 2014*
  • HIV-1 Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • HIV-1 Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of HIV-1 Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • HIV-1 Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • HIV-1 Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of HIV-1 Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • HIV-1 Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • HIV-1 Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • HIV-1 Infection Therapeutics, Global, Clinical Trials by Phase, 2014*
  • HIV-1 Infection Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • HIV-1 Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • HIV-1 Infection Therapeutics, Global, Suspended Clinical Trials, 2014*
  • HIV-1 Infection Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • HIV-1 Infection Therapeutics, Global, Terminated Clinical Trials, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • HIV-1 Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen R&D Ireland, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by French National Agency for Research on AIDS and Viral Hepatitis, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by AIDS Clinical Trials Group, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Clinic de Barcelona, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University of North Carolina, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by International Partnership For Microbicides, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Research Council, 2014*

List of Figures

  • HIV-1 Infection Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • HIV-1 Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • HIV-1 Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of HIV-1 Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • HIV-1 Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • HIV-1 Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of HIV-1 Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • HIV-1 Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • HIV-1 Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • HIV-1 Infection Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • HIV-1 Infection Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • HIV-1 Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • HIV-1 Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • HIV-1 Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top